8-K/A XBRL

8-K/A

Company: HALOZYME THERAPEUTICS, INC.
Filed: November 2, 2021
Period of Report: November 2, 2021
Accession Number: 0001159036-21-000052

View Document ↗ View on SEC.gov ↗